09 de setembro, 2020 | 12h00 | Webinar – Plataforma ZOOM
Resumo da apresentação:
Melanoma is the deadliest form of skin cancer, and in the last years, incidence has risen faster than almost any other cancer. Targeted therapies, like BRAF and MEK inhibitors, improved the outcome of melanoma patients, however they ultimately develop resistance, promoting the identification of new therapeutic biomarkers.
SPINT2 has been identified as a tumor suppressor gene in various solid tumors and shown to have a role in melanoma aggressiveness, cell migration and proliferation capacity. This protein is a serine protease inhibitor that regulates several cellular functions and signaling pathways, including the HGF/MET pathway. Still, it remains inconclusive how SPINT2 influences melanoma microenvironment, aggressiveness and response to therapy. This presentation will focus on the preliminary results from our group aiming to further understand the tumorigenic role of SPINT2 in melanoma and the influence of this tumor suppressor gene on targeted therapies’ efficiency. Our results propose SPINT2 as a potential therapeutic biomarker towards a more personalized treatment of melanoma patients.
Biography:
Marta Viana-Pereira is a Researcher at Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho and a first-year medical resident at Hospital de Braga. She holds a degree in Applied Biology by the School of Sciences, University of Minho (2005), completed her PhD in Health Sciences by the School of Medicine, University of Minho (2011), awarded with a PhD grant from the Portuguese Science Foundation (FCT), and concluded her Medical Degree by the Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto (2019). During her PhD, Marta was also a visiting research fellow at The Institute of Cancer Research, London, UK (2008-2009). She has 8 years of postdoctoral experience at the School of Medicine, University of Minho (2011-2019). Marta has worked with different tumor models, having acquired a broad experience in the Oncobiology research field, and with the recent Medical Degree she aims to add a clinical significance into her research.
Marta has published several international peer-reviewed research articles and book chapters; supervised 2 Master’s theses and several under-graduated and post-graduated research projects. Her research team has been awarded with several national and international awards.
Gratuito
Para assistir basta aceder ao link abaixo, no dia e hora agendada.
Link de acesso: https://zoom.us/j/95133692480
IINFACTS - Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde CBAS_4Ed. - Programa Doutoral em Ciências Biológicas Aplicadas à Saúde do IUCS
17 de julho, 2020 | 15h00 | Webinar – Plataforma ZOOM
Resumo da apresentação:
Micro and nanoscale drug delivery strategies have been used to increase drug biodistribution and halflives, control the release rates of drugs, and enable the precise targeting of drugs to biological sites of interest. Drug carriers can range in size from nanoparticles to wearable or implantable macroscale drug reservoirs. However, drug carriers with micro or nanoscale features are particularly attractive, as these carriers can interact with biological systems on the same length scale as cells and cellular processes. While such drug carriers show promise in improving pharmacokinetics and therapeutic outcomes, achieving effective delivery to target sites remains a challenge. To achieve efficient drug release, different types of engineered drug carriers can be formulated with different types of polymer. In this project, different approaches about formulation of controlled release systems will be discussed, since traditional methods of production, microfluidics technique to 3D-printing. 3D-printing of microparticles will provide a pre-programmed delayed and pulsatile drug release profile of an encapsulated therapeutic. The advantage of this technique lies in its ability to access a range of membrane degradation rates from a single polymer matrix material.
Biography:
Flávia Sousa is a Researcher Associate at Imperial College London at Stevens Group in the Department of Materials and Bioengineering. She received her master’s degree in Pharmaceutical Sciences in 2013 at IUCS and in 2019 completed her PhD in Biomedical Sciences, developed at i3S (Porto, Portugal), INL
(International Iberian Nanotechnology Laboratory, Braga, Portugal), Aalborg University (Aalborg, Denmark) and Northeastern University (Boston, USA).
Flávia Sousa is mainly interested in the nanomedicine field, where she built a solid foundation in nanobiomaterials-based nanocarriers for cancer treatment, especially glioblastoma. In the past years, she has accumulated various scientific awards and prestigious recognitions. Also, she is a member of
the Young Committee of Spanish Portuguese Chapter of the Controlled Release Society, member of Young Scientist Committee of Controlled Release Society, first vowel of the Fiscal Council of Portuguese American Postgraduate Society and belongs to a board of CRS Focus Group in Nanomedicine and Nanoscale Delivery as Trainee Representative.
Gratuito – Inscrição obrigatória em: AQUI
IINFACTS - Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde CBAS_4Ed. - Programa Doutoral em Ciências Biológicas Aplicadas à Saúde do IUCS
4th July, 2019
Prof. Júlio Souza
Prof. Hassan Bousbaa
CESPU, Campus Universitário de Gandra
Auditório 3
18th July, 2019
Undergraduate and postgraduate students, teachers, researchers and professionals integrated in CESPU's academic and scientific community.
Free.
CESPU, Cooperativa de Ensino Superior Politécnico e Universitário, crl, Rua Central de Gandra, 1317, 4585-116 Gandra PRD | Portugal
09 a 11 de julho, 2019
Até 03/06/2019 através de: https://s.up.pt/xy9o
Estudantes FFUP (1º, 2º e 3º ciclos) e funcionários FFUP: inscrição é gratuita
Estudantes de 1º e 2º ciclos: 50 Euros
Estudantes de 3º ciclo: 70 Euros
Outros: 90 Euros
Laboratório de Química Orgânica e Farmacêutica (LQOF) da FFUP e Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR) em colaboração com i3DU - Medicines and Pharmaceutical Innovation (PhD Programme); IINFACTS; Rotoquímica - Equipamento Científico de Laboratório, Lda
Anfiteatro 10 do Complexo FFUP/ICBAS
04th May, 2019
Training in Good Practices in Clinical Research: for an international ethical and scientific quality in conducting clinical studies in humans.
CESPU, Campus Universitário de Gandra
16 de maio, 2019
Entrada Gratuita, mas sujeita a inscrição prévia.
Professora Doutora Begoña Criado
Professora Doutora Lurdes Teixeira
Professora Doutora Sara Lima
Alunos do 1º ano do CTeSP em Gerontologia 2018/2019
Auditório da Escola Superior de Saúde do Vale do Ave
18th may, 2019
Registration Fees
Students - 40€ | Students Basic Fee - 20€ (Only Attendance) | Professionals - 90€ | SOPIO member - 50% discount
Registrations are made through the submission form and the payment by bank transfer.
Fees include lunch, coffee breaks, and the book of abstracts (except the student basic fee) Every attendant is invited to submit an abstract and/or poster without any additional fee.
Azurém Campus, Minho University
Guimarães - Portugal
27 de fevereiro 2019 | 15h00 | Sala 3042
Tiago André dos Santos Martins Peixoto, MSc - Doutorando em Ciências da Enfermagem na UP-ICBAS
Entrada livre | Certificado de presença a pedido
Instituto Universitário de Ciências da Saúde (IUCS)-CESPU | IINFACTS - Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde
CESPU
Campus Universitário de Gandra
27 de fevereiro 2019 | 15h00 | Sala 3042
Nuno Miguel dos Santos Martins Peixoto, MSc - Doutorando em Ciências da Enfermagem na UP-ICBAS
Entrada livre | Certificado de presença a pedido
Instituto Universitário de Ciências da Saúde (IUCS)-CESPU | IINFACTS - Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde
CESPU
Campus Universitário de Gandra